The burgeoning landscape of novel treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual mode agonists targeting the GLP-1 and GIP receptors. While sharing a similar https://mohamadbnkf759398.wikilentillas.com/1964645/retatrutide_vs_tirzepatide_a_comparative_analysis